TY - STD TI - WHO. Guidelines for the treatment of malaria (second edition). Geneva: World Health Organization; 2010. [http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf]. UR - http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf ID - ref1 ER - TY - JOUR AU - Mishra, N. AU - Singh, J. P. AU - Srivastava, B. AU - Arora, U. AU - Shah, N. K. AU - Ghosh, S. K. PY - 2012 DA - 2012// TI - Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009–2010 JO - Bull World Health Organ VL - 90 ID - Mishra2012 ER - TY - JOUR AU - Dua, V. K. AU - Kar, P. K. AU - Sharma, V. P. PY - 1996 DA - 1996// TI - Chloroquine resistant 22. Plasmodium vivax malaria in India JO - Trop Med Int Health VL - 1 UR - https://doi.org/10.1111/j.1365-3156.1996.tb00116.x DO - 10.1111/j.1365-3156.1996.tb00116.x ID - Dua1996 ER - TY - JOUR AU - Baird, J. K. PY - 2004 DA - 2004// TI - Chloroquine resistance in Plasmodium vivax JO - Antimicrob Agents Chemother VL - 48 UR - https://doi.org/10.1128/AAC.48.11.4075-4083.2004 DO - 10.1128/AAC.48.11.4075-4083.2004 ID - Baird2004 ER - TY - STD TI - WHO. World Malaria Report. Geneva: World Health Organization. 2013. ID - ref5 ER - TY - JOUR AU - Battle, K. E. AU - Karhunen, M. S. AU - Bhatt, S. AU - Gething, P. W. AU - Howes, R. E. AU - Golding, N. PY - 2014 DA - 2014// TI - Geographical variation in Plasmodium vivax relapse JO - Malar J VL - 13 UR - https://doi.org/10.1186/1475-2875-13-144 DO - 10.1186/1475-2875-13-144 ID - Battle2014 ER - TY - STD TI - National Institute of Malaria Research, national vector borne disease control programme: guidelines for diagnosis and treatment of malaria in India. Government of India. 2011. [http://mrcindia.org/TreatmentGuidelineswithAddendum.pdf]. UR - http://mrcindia.org/TreatmentGuidelineswithAddendum.pdf ID - ref7 ER - TY - STD TI - National vector borne disease control programme. Directorate General of Health Services Ministry of Health and Family Welfare: National drug policy on malaria. Government of India. 2013. [http://www.nvbdcp.gov.in/Doc/National-Drug-Policy-2013.pdf]. UR - http://www.nvbdcp.gov.in/Doc/National-Drug-Policy-2013.pdf ID - ref8 ER - TY - STD TI - US Prescribing Information “Primaquine phosphate tablets”. Feb 2013. [http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bfbf4ae-81b8-4160-a00d-6322aadd4b59]. UR - http://dailymed.nlm.nih.gov/dailymed/lookup.cfm%3fsetid%3d1bfbf4ae-81b8-4160-a00d-6322aadd4b59 ID - ref9 ER - TY - JOUR AU - Teka, H. AU - Petros, B. AU - Yamuah, L. AU - Tesfaye, G. AU - Elhassan, I. AU - Muchohi, S. PY - 2008 DA - 2008// TI - Chloroquine-resistant: Plasmodium vivax malaria in Debre Zeit, Ethiopia JO - Malar J VL - 7 UR - https://doi.org/10.1186/1475-2875-7-220 DO - 10.1186/1475-2875-7-220 ID - Teka2008 ER - TY - STD TI - World Health Organization. Monitoring antimalarial drug resistance. Report of a WHO consultation. Geneva, Switzerland. 3–5 December. 2001. [http://malaria.who.int/cmc_upload/0/000/015/800/200239.html]. UR - http://malaria.who.int/cmc_upload/0/000/015/800/200239.html ID - ref11 ER - TY - STD TI - Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009; 3:CD007483. DOI:10.1002/14651858.CD007483.pub2. ID - ref12 ER - TY - JOUR AU - Ratcliff, A. AU - Siswantoro, H. AU - Kenangalem, E. AU - Maristela, R. AU - Wuwung, R. M. AU - Laihad, F. PY - 2007 DA - 2007// TI - Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: open label randomized comparison JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60160-3 DO - 10.1016/S0140-6736(07)60160-3 ID - Ratcliff2007 ER - TY - JOUR AU - Davis, T. M. AU - Hung, T. Y. AU - Sim, I. K. AU - Karunajeewa, H. A. AU - Ilett, K. F. PY - 2005 DA - 2005// TI - Piperaquine: a resurgent antimalarial drug JO - Drugs VL - 65 UR - https://doi.org/10.2165/00003495-200565010-00004 DO - 10.2165/00003495-200565010-00004 ID - Davis2005 ER - TY - STD TI - Saha N1, Moehrle JJ, Zutshi A, Sharma P, Kaur P, Iyer SS. Safety, tolerability and pharmacokinetic profile of single and multiple oral doses of arterolane (RBx11160) maleate in healthy subjects. J Clin Pharmacol. 2014;54:386–93. ID - ref15 ER - TY - JOUR AU - Ahmed, T. AU - Sharma, P. AU - Gautam, A. AU - Varshney, B. AU - Kothari, M. AU - Ganguly, S. PY - 2008 DA - 2008// TI - Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects JO - J Clin Pharmacol VL - 48 UR - https://doi.org/10.1177/0091270007310384 DO - 10.1177/0091270007310384 ID - Ahmed2008 ER - TY - STD TI - Guidance for industry, bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM). May 2001. ID - ref17 ER - TY - JOUR AU - Mendis, K. AU - Sina, B. J. AU - Marchesini, P. AU - Carter, R. PY - 2001 DA - 2001// TI - The neglected burden of Plasmodium vivax malaria JO - Am J Trop Med Hyg VL - 64 ID - Mendis2001 ER - TY - JOUR AU - Ratcliff, A. AU - Siswantoro, H. AU - Kenangalem, E. AU - Wuwung, M. AU - Brockman, A. PY - 2007 DA - 2007// TI - Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia JO - Trans R Soc Trop Med Hyg VL - 101 UR - https://doi.org/10.1016/j.trstmh.2006.06.008 DO - 10.1016/j.trstmh.2006.06.008 ID - Ratcliff2007 ER - TY - JOUR AU - Pukrittayakamee, S. AU - Chantra, A. AU - Simpson, J. A. AU - Vanijanonta, S. AU - Clemens, R. AU - Looareesuwan, S. PY - 2000 DA - 2000// TI - Therapeutic responses to different antimalarial drugs in vivax malaria JO - Antimicrob Agents Chemother VL - 44 UR - https://doi.org/10.1128/AAC.44.6.1680-1685.2000 DO - 10.1128/AAC.44.6.1680-1685.2000 ID - Pukrittayakamee2000 ER - TY - STD TI - deVries PJ, Dien TK: Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996;52: 818–36. ID - ref21 ER - TY - JOUR AU - Valecha, N. AU - Krudsood, S. AU - Tangpukdee, N. AU - Mohanty, S. AU - Sharma, S. K. AU - Tyagi, P. K. PY - 2012 DA - 2012// TI - Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis475 DO - 10.1093/cid/cis475 ID - Valecha2012 ER - TY - STD TI - Data on file Ranbaxy. A Phase 3, Double blind, Randomised study of arterolane maleate + Piperaquine phosphate Versus artemether–lumefantrine for falciparum malaria in Asia and Africa. ID - ref23 ER - TY - JOUR AU - Eibach, D. AU - Ceron, N. AU - Krishnalall, K. AU - Carter, K. AU - Bonnot, G. AU - Bienvenu, A. L. PY - 2012 DA - 2012// TI - Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana JO - Malar J VL - 11 UR - https://doi.org/10.1186/1475-2875-11-347 DO - 10.1186/1475-2875-11-347 ID - Eibach2012 ER - TY - JOUR AU - Mytton, O. T. AU - Ashley, E. A. AU - Peto, L. AU - Price, R. N. AU - La, Y. AU - Hae, R. PY - 2007 DA - 2007// TI - Electrocardiographic safety evaluation of dihydroartemisinin–piperaquine in the treatment of uncomplicated falciparum malaria JO - Am J Trop Med Hyg VL - 77 ID - Mytton2007 ER - TY - JOUR AU - Yap, Y. G. AU - Camm, A. J. PY - 2003 DA - 2003// TI - Drug induced QT prolongation and Torsades de Pointes JO - Heart VL - 89 UR - https://doi.org/10.1136/heart.89.11.1363 DO - 10.1136/heart.89.11.1363 ID - Yap2003 ER - TY - JOUR AU - Na-Bangchang, K. AU - Limpaibul, L. AU - Thanavibul, A. AU - Tan-Ariya, P. AU - Karbwang, J. PY - 1994 DA - 1994// TI - The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria JO - Br J Clin Pharmacol VL - 38 UR - https://doi.org/10.1111/j.1365-2125.1994.tb04354.x DO - 10.1111/j.1365-2125.1994.tb04354.x ID - Na-Bangchang1994 ER -